Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
50
HYFM Quote, Financials, Valuation and Earnings
Last price:
$4.39
Seasonality move
:
-5.86%
Day range:
$4.28 - $4.47
52-week range:
$1.50 - $8.55
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.11x
P/B ratio:
0.10x
Volume:
11.8K
Avg. volume:
9.8K
1-year change:
-35.82%
Market cap:
$20M
Revenue:
$190.3M
EPS (TTM):
-$14.92
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $342.2M | $479.4M | $344.5M | $226.6M | $190.3M | |
| Revenue Growth (YoY) | 45.55% | 40.1% | -28.14% | -34.23% | -16.02% | |
| Cost of Revenues | $278.6M | $377.9M | $315.2M | $189M | $158.2M | |
| Gross Profit | $63.6M | $101.5M | $29.3M | $37.6M | $32.1M | |
| Gross Profit Margin | 18.6% | 21.17% | 8.52% | 16.6% | 16.89% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $58.5M | $104.2M | $118.6M | $87.3M | $72.8M | |
| Other Inc / (Exp) | -$1.7M | -$884K | -$191.6M | $118K | -$10M | |
| Operating Expenses | $58.5M | $104.2M | $118.6M | $87.3M | $72.8M | |
| Operating Income | $5.1M | -$2.7M | -$89.3M | -$49.7M | -$40.7M | |
| Net Interest Expenses | $10.1M | $2.1M | $11M | $15.4M | $15.2M | |
| EBT. Incl. Unusual Items | -$6.7M | -$5.7M | -$291.9M | -$65M | -$65.8M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $576K | -$19.1M | -$6.4M | -$213K | $869K | |
| Net Income to Company | -$7.3M | $13.4M | -$285.4M | -$64.8M | -$66.7M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$7.3M | $13.4M | -$285.4M | -$64.8M | -$66.7M | |
| Basic EPS (Cont. Ops) | -$4.60 | $3.40 | -$63.50 | -$14.24 | -$14.51 | |
| Diluted EPS (Cont. Ops) | -$4.60 | $3.10 | -$63.50 | -$14.24 | -$14.51 | |
| Weighted Average Basic Share | $2.1M | $4M | $4.5M | $4.6M | $4.6M | |
| Weighted Average Diluted Share | $2.1M | $4.3M | $4.5M | $4.6M | $4.6M | |
| EBITDA | $10.2M | $11.4M | -$239.4M | -$17.5M | -$19.9M | |
| EBIT | $3.4M | -$3.6M | -$280.9M | -$49.6M | -$50.6M | |
| Revenue (Reported) | $342.2M | $479.4M | $344.5M | $226.6M | $190.3M | |
| Operating Income (Reported) | $5.1M | -$2.7M | -$89.3M | -$49.7M | -$40.7M | |
| Operating Income (Adjusted) | $3.4M | -$3.6M | -$280.9M | -$49.6M | -$50.6M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $111.4M | $111.4M | $62.2M | $54.2M | $40.5M | |
| Revenue Growth (YoY) | 66.51% | -0.01% | -44.17% | -12.88% | -25.18% | |
| Cost of Revenues | $88.2M | $94.8M | $50.8M | $43.2M | $33.7M | |
| Gross Profit | $23.2M | $16.6M | $11.4M | $10.9M | $6.9M | |
| Gross Profit Margin | 20.85% | 14.91% | 18.3% | 20.17% | 16.97% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $16.8M | $40.2M | $24.4M | $19.6M | $17.9M | |
| Other Inc / (Exp) | -$596K | -$2.9M | $40K | $215K | $60K | |
| Operating Expenses | $16.8M | $40.2M | $24.4M | $19.6M | $17.9M | |
| Operating Income | $6.4M | -$23.6M | -$13.1M | -$8.7M | -$11M | |
| Net Interest Expenses | $90K | $2.4M | $3.7M | $3.9M | $3.4M | |
| EBT. Incl. Unusual Items | $5.7M | -$28.9M | -$16.7M | -$12.4M | -$14.3M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $756K | -$5.6M | $147K | $196K | $82K | |
| Net Income to Company | $4.9M | -$23.3M | -$16.8M | -$12.6M | -$14.4M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $4.9M | -$23.3M | -$16.8M | -$12.6M | -$14.4M | |
| Basic EPS (Cont. Ops) | $1.50 | -$5.20 | -$3.70 | -$2.75 | -$3.12 | |
| Diluted EPS (Cont. Ops) | $1.30 | -$5.20 | -$3.70 | -$2.75 | -$3.12 | |
| Weighted Average Basic Share | $3.4M | $4.5M | $4.5M | $4.6M | $4.6M | |
| Weighted Average Diluted Share | $3.9M | $4.5M | $4.5M | $4.6M | $4.6M | |
| EBITDA | $7.4M | -$9.6M | -$5M | -$596K | -$3.6M | |
| EBIT | $5.8M | -$26.5M | -$13M | -$8.5M | -$10.9M | |
| Revenue (Reported) | $111.4M | $111.4M | $62.2M | $54.2M | $40.5M | |
| Operating Income (Reported) | $6.4M | -$23.6M | -$13.1M | -$8.7M | -$11M | |
| Operating Income (Adjusted) | $5.8M | -$26.5M | -$13M | -$8.5M | -$10.9M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $386.7M | $479.4M | $295.3M | $218.6M | $176.7M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $311.4M | $384.5M | $271.2M | $181.4M | $148.6M | |
| Gross Profit | $75.3M | $94.9M | $24.1M | $37.2M | $28.1M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $63.6M | $127.6M | $102.8M | $82.5M | $71M | |
| Other Inc / (Exp) | -$2.3M | -$3.1M | -$188.7M | $293K | -$10.1M | |
| Operating Expenses | $63.6M | $127.6M | $102.8M | $82.5M | $71M | |
| Operating Income | $11.7M | -$32.7M | -$78.7M | -$45.3M | -$43M | |
| Net Interest Expenses | $7.4M | $4.4M | $12.3M | $15.7M | $14.7M | |
| EBT. Incl. Unusual Items | $1.9M | -$40.3M | -$279.7M | -$60.7M | -$67.7M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $1.2M | -$25.5M | -$727K | -$164K | $755K | |
| Net Income to Company | $760K | -$14.8M | -$279M | -$60.6M | -$68.5M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $760K | -$14.8M | -$279M | -$60.6M | -$68.5M | |
| Basic EPS (Cont. Ops) | -$1.44 | -$3.20 | -$62.00 | -$13.29 | -$14.92 | |
| Diluted EPS (Cont. Ops) | -$1.64 | -$3.50 | -$62.00 | -$13.29 | -$14.92 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $16M | -$5.6M | -$234.8M | -$13.1M | -$22.9M | |
| EBIT | $9.4M | -$35.9M | -$267.4M | -$45.1M | -$53.1M | |
| Revenue (Reported) | $386.7M | $479.4M | $295.3M | $218.6M | $176.7M | |
| Operating Income (Reported) | $11.7M | -$32.7M | -$78.7M | -$45.3M | -$43M | |
| Operating Income (Adjusted) | $9.4M | -$35.9M | -$267.4M | -$45.1M | -$53.1M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $111.4M | $111.4M | $62.2M | $54.2M | $40.5M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $88.2M | $94.8M | $50.8M | $43.2M | $33.7M | |
| Gross Profit | $23.2M | $16.6M | $11.4M | $10.9M | $6.9M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $16.8M | $40.2M | $24.4M | $19.6M | $17.9M | |
| Other Inc / (Exp) | -$596K | -$2.9M | $40K | $215K | $60K | |
| Operating Expenses | $16.8M | $40.2M | $24.4M | $19.6M | $17.9M | |
| Operating Income | $6.4M | -$23.6M | -$13.1M | -$8.7M | -$11M | |
| Net Interest Expenses | $90K | $2.4M | $3.7M | $3.9M | $3.4M | |
| EBT. Incl. Unusual Items | $5.7M | -$28.9M | -$16.7M | -$12.4M | -$14.3M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $756K | -$5.6M | $147K | $196K | $82K | |
| Net Income to Company | $4.9M | -$23.3M | -$16.8M | -$12.6M | -$14.4M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $4.9M | -$23.3M | -$16.8M | -$12.6M | -$14.4M | |
| Basic EPS (Cont. Ops) | $1.50 | -$5.20 | -$3.70 | -$2.75 | -$3.12 | |
| Diluted EPS (Cont. Ops) | $1.30 | -$5.20 | -$3.70 | -$2.75 | -$3.12 | |
| Weighted Average Basic Share | $3.4M | $4.5M | $4.5M | $4.6M | $4.6M | |
| Weighted Average Diluted Share | $3.9M | $4.5M | $4.5M | $4.6M | $4.6M | |
| EBITDA | $7.4M | -$9.6M | -$5M | -$596K | -$3.6M | |
| EBIT | $5.8M | -$26.5M | -$13M | -$8.5M | -$10.9M | |
| Revenue (Reported) | $111.4M | $111.4M | $62.2M | $54.2M | $40.5M | |
| Operating Income (Reported) | $6.4M | -$23.6M | -$13.1M | -$8.7M | -$11M | |
| Operating Income (Adjusted) | $5.8M | -$26.5M | -$13M | -$8.5M | -$10.9M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $75.2M | $26.6M | $21.3M | $30.3M | $26.1M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $19.3M | $34.4M | $16.6M | $15.8M | $13.4M | |
| Inventory | $88.6M | $189.1M | $111.4M | $75.4M | $50.6M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $9.6M | $9.8M | $5M | $5.5M | $3.7M | |
| Total Current Assets | $199.9M | $269.4M | $154.9M | $128.1M | $95.2M | |
| Property Plant And Equipment | $22.3M | $95.7M | $116.4M | $101.9M | $80.4M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | $204.9M | -- | -- | -- | |
| Other Intangibles | $52.4M | $314.8M | $300.4M | $275.9M | $249M | |
| Other Long-Term Assets | $1.2M | $6.5M | $1.8M | $1.8M | $1.5M | |
| Total Assets | $275.8M | $891.2M | $573.6M | $507.6M | $426.1M | |
| Accounts Payable | $22.6M | $26.7M | $13.6M | $12.6M | $12.3M | |
| Accrued Expenses | $11.1M | $29.6M | $10.2M | $6.7M | $8.2M | |
| Current Portion Of Long-Term Debt | $746K | $2.3M | $1.3M | $3M | $1.3M | |
| Current Portion Of Capital Lease Obligations | $3.7M | $7.2M | $9.8M | $9.3M | $8.2M | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $48.7M | $88.4M | $41.6M | $37.7M | $35M | |
| Long-Term Debt | $290K | $119.5M | $117.5M | $115.4M | $114.7M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $64.9M | $256.1M | $223.7M | $217M | $202.4M | |
| Common Stock | $3K | $4K | $5K | -- | -- | |
| Other Common Equity Adj | $599K | -$1.4M | -$7.2M | -$6.5M | -$8.9M | |
| Common Equity | $210.9M | $635.2M | $349.9M | $290.6M | $223.7M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $210.9M | $635.2M | $349.9M | $290.6M | $223.7M | |
| Total Liabilities and Equity | $275.8M | $891.2M | $573.6M | $507.6M | $426.1M | |
| Cash and Short Terms | $75.2M | $26.6M | $21.3M | $30.3M | $26.1M | |
| Total Debt | $1M | $121.8M | $118.8M | $118.4M | $116M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $60.3M | $12.2M | $18.7M | $24.2M | $13.7M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $32.5M | $42.6M | $21.7M | $21.4M | $19.7M | |
| Inventory | $96.3M | $190M | $103.4M | $72.3M | $49.9M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $13.8M | $11.3M | $6.1M | $5M | $4.1M | |
| Total Current Assets | $205.7M | $261M | $150.8M | $124M | $88.7M | |
| Property Plant And Equipment | $21.1M | $105.9M | $112.1M | $98.5M | $77.3M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | $183.3M | -- | -- | -- | |
| Other Intangibles | -- | $327M | $294.3M | $269.8M | $243.1M | |
| Other Long-Term Assets | $4.6M | $4.2M | $1.9M | $1.8M | $1.5M | |
| Total Assets | $282.7M | $881.5M | $559.3M | $494M | $410.6M | |
| Accounts Payable | $36.8M | $36.4M | $13.2M | $15.4M | $16.1M | |
| Accrued Expenses | $9.6M | $27.3M | $7.4M | $7.7M | $4.5M | |
| Current Portion Of Long-Term Debt | $822K | $2.3M | $1.4M | $1.3M | $5.9M | |
| Current Portion Of Capital Lease Obligations | $3.8M | $7.8M | $10M | $9.3M | $8.3M | |
| Other Current Liabilities | $500K | -- | -- | -- | -- | |
| Total Current Liabilities | $55.6M | $88.9M | $37.2M | $39.3M | $39.9M | |
| Long-Term Debt | $238K | $119.2M | $117.4M | $115.4M | $110M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $70.8M | $266M | $225.1M | $216M | $200.6M | |
| Common Stock | $3K | $4K | $5K | $5K | -- | |
| Other Common Equity Adj | $822K | $802K | -$7.1M | -$7.2M | -$8.8M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $211.8M | $615.5M | $334.2M | $278M | $209.9M | |
| Total Liabilities and Equity | $282.7M | $881.5M | $559.3M | $494M | $410.6M | |
| Cash and Short Terms | $60.3M | $12.2M | $18.7M | $24.2M | $13.7M | |
| Total Debt | $1.1M | $121.5M | $118.7M | $116.7M | $115.8M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$7.3M | $13.4M | -$285.4M | -$64.8M | -$66.7M | |
| Depreciation & Amoritzation | -- | $14.9M | $41.5M | $32.1M | $30.7M | |
| Stock-Based Compensation | $8.9M | $5M | $8.4M | $5.1M | $2.4M | |
| Change in Accounts Receivable | -$6.3M | -$1.9M | $16.7M | $766K | $1.6M | |
| Change in Inventories | -$36.9M | -$46.8M | $57M | $26.1M | $14.4M | |
| Cash From Operations | -$44.8M | -$45.1M | $22M | $7M | -$324K | |
| Capital Expenditures | $1.4M | $5.4M | $8.2M | $4.2M | $2.9M | |
| Cash Acquisitions | -- | -$462.2M | $190K | -- | -- | |
| Cash From Investing | $546K | -$468.2M | -$8.5M | -$4.2M | $1.7M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $309.2M | $262.5M | $853K | $9.6M | $378K | |
| Long-Term Debt Repaid | -$404M | -$143M | -$2.4M | -$3.2M | -$5M | |
| Repurchase of Common Stock | -$2.6M | -- | -- | -- | -- | |
| Other Financing Activities | -$687K | -$21.4M | -$18.7M | -$271K | -$142K | |
| Cash From Financing | $88.1M | $464.7M | -$20.2M | $6.1M | -$4.8M | |
| Beginning Cash (CF) | $32.9M | $77M | $28.4M | $21.3M | $30.3M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $43.9M | -$48.5M | -$6.7M | $8.9M | -$3.4M | |
| Ending Cash (CF) | $77M | $28.4M | $21.3M | $30.3M | $26.1M | |
| Levered Free Cash Flow | -$46.3M | -$50.5M | $13.8M | $2.8M | -$3.2M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $4.9M | -$23.3M | -$16.8M | -$12.6M | -$14.4M | |
| Depreciation & Amoritzation | -- | -- | -- | $7.9M | $7.3M | |
| Stock-Based Compensation | $1M | $2.9M | $1.2M | $853K | $474K | |
| Change in Accounts Receivable | -$11.6M | -$6.8M | -$5.1M | -$5.7M | -$6.8M | |
| Change in Inventories | -$7.5M | -$143K | $7.3M | $2.2M | $413K | |
| Cash From Operations | -$2.6M | -$10.2M | -$9M | -$2.3M | -$11.8M | |
| Capital Expenditures | $428K | $2.5M | $1.7M | $1.4M | $244K | |
| Cash Acquisitions | -- | $190K | -- | -- | -- | |
| Cash From Investing | -$445K | -$2.4M | -$1.6M | -$1.4M | -$248K | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $52.3M | $420K | $8.8M | $158K | $95K | |
| Long-Term Debt Repaid | -$52.3M | -$710K | -$685K | -$2.4M | -$505K | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$11.9M | -$1.7M | -$123K | -$97K | -$3K | |
| Cash From Financing | -$11.8M | -$2M | $8M | -$2.4M | -$413K | |
| Beginning Cash (CF) | $77M | $28.4M | $21.3M | $30.3M | $26.1M | |
| Foreign Exchange Rate Adjustment | -$4K | $43K | $5K | -$97K | $41K | |
| Additions / Reductions | -$14.9M | -$14.5M | -$2.6M | -$6.1M | -$12.4M | |
| Ending Cash (CF) | $62M | $13.9M | $18.7M | $24.2M | $13.7M | |
| Levered Free Cash Flow | -$3.1M | -$12.6M | -$10.6M | -$3.7M | -$12M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $760K | -$14.8M | -$279M | -$60.6M | -$68.5M | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | $9.9M | $6.9M | $6.6M | $4.7M | $2M | |
| Change in Accounts Receivable | -$7.8M | $2.8M | $18.4M | $192K | $563K | |
| Change in Inventories | -$48.7M | -$39.5M | $64.5M | $20.9M | $12.7M | |
| Cash From Operations | -$45.7M | -$52.6M | $23.2M | $13.7M | -$9.8M | |
| Capital Expenditures | $1.8M | $7.4M | $7.4M | $4M | $1.7M | |
| Cash Acquisitions | -- | -$462M | -- | -- | -- | |
| Cash From Investing | -$1.8M | -$470.1M | -$7.7M | -$4M | $2.8M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $310M | $210.6M | $9.2M | $954K | $315K | |
| Long-Term Debt Repaid | -$399.8M | -$91.5M | -$2.3M | -$5M | -$3.1M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$12.4M | -$11.1M | -$17.2M | -$245K | -$48K | |
| Cash From Financing | $77.6M | $474.6M | -$10.3M | -$4.3M | -$2.8M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $30M | -$48.1M | $5.2M | $5.5M | -$9.8M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -$47.5M | -$60M | $15.8M | $9.7M | -$11.5M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $4.9M | -$23.3M | -$16.8M | -$12.6M | -$14.4M | |
| Depreciation & Amoritzation | -- | -- | -- | $7.9M | $7.3M | |
| Stock-Based Compensation | $1M | $2.9M | $1.2M | $853K | $474K | |
| Change in Accounts Receivable | -$11.6M | -$6.8M | -$5.1M | -$5.7M | -$6.8M | |
| Change in Inventories | -$7.5M | -$143K | $7.3M | $2.2M | $413K | |
| Cash From Operations | -$2.6M | -$10.2M | -$9M | -$2.3M | -$11.8M | |
| Capital Expenditures | $428K | $2.5M | $1.7M | $1.4M | $244K | |
| Cash Acquisitions | -- | $190K | -- | -- | -- | |
| Cash From Investing | -$445K | -$2.4M | -$1.6M | -$1.4M | -$248K | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $52.3M | $420K | $8.8M | $158K | $95K | |
| Long-Term Debt Repaid | -$52.3M | -$710K | -$685K | -$2.4M | -$505K | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$11.9M | -$1.7M | -$123K | -$97K | -$3K | |
| Cash From Financing | -$11.8M | -$2M | $8M | -$2.4M | -$413K | |
| Beginning Cash (CF) | $77M | $28.4M | $21.3M | $30.3M | $26.1M | |
| Foreign Exchange Rate Adjustment | -$4K | $43K | $5K | -$97K | $41K | |
| Additions / Reductions | -$14.9M | -$14.5M | -$2.6M | -$6.1M | -$12.4M | |
| Ending Cash (CF) | $62M | $13.9M | $18.7M | $24.2M | $13.7M | |
| Levered Free Cash Flow | -$3.1M | -$12.6M | -$10.6M | -$3.7M | -$12M | |
Get HYFM Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
HYFM
Sector
P/E ratio
--
18.58x
PEG ratio
-0.02x
0.25x
P/B ratio
0.10x
1.75x
Price / LTM sales
0.11x
0.94x
Growth Metrics
HYFM
Sector
Revenue growth
-25.18%
1.98%
Earnings growth
--
2.46%
Revenue (5-year growth)
-4.14%
4.35%
Earnings forecast
-$2.20
$0.40
Profitability
HYFM
Sector
Profitability FY 2024
$32.1M
$393.9M
Return on invested capital
-19.12%
5.32%
Return on assets
-15.29%
3.49%
Return on equity
-28.31%
8.55%
Earnings Date
Last Earnings Date
May
13
Next Earnings Date
Aug
8
Estimated Next Earnings Date
Aug
12
Balance Sheet
HYFM
Sector
Total cash
$13.7M
$154.3M
Short term investments
--
$35.5M
Total assets
$426.1M
$1.7B
Long term debt
$115.8M
$252.4M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
71
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 59x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
68
MCRI alert for Jul 18
Monarch Casino & Resort [MCRI] is up 19.81% over the past day.
Sell
41
NEGG alert for Jul 18
Newegg Commerce [NEGG] is up 17.85% over the past day.
Buy
72
MNPR alert for Jul 18
Monopar Therapeutics [MNPR] is up 13.2% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
